Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma?
Background: Cytokeratin 19-positive (CK19(+)) hepatocellular carcinomas (HCC) are generally associated with poor prognosis after hepatectomy. It is typically detected from postoperative immunochemistry. We have analyzed several clinically available biomarkers, in particular, neutrophil to lymphocyte...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a95080fe17b74e3cad83ec35b9eacc90 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a95080fe17b74e3cad83ec35b9eacc90 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a95080fe17b74e3cad83ec35b9eacc902021-11-25T18:06:57ZDoes Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma?10.3390/jpm111110782075-4426https://doaj.org/article/a95080fe17b74e3cad83ec35b9eacc902021-10-01T00:00:00Zhttps://www.mdpi.com/2075-4426/11/11/1078https://doaj.org/toc/2075-4426Background: Cytokeratin 19-positive (CK19(+)) hepatocellular carcinomas (HCC) are generally associated with poor prognosis after hepatectomy. It is typically detected from postoperative immunochemistry. We have analyzed several clinically available biomarkers, in particular, neutrophil to lymphocyte ratio (NLR) and aim to develop a panel of biomarkers in identifying CK19 expression in (HCC) preoperatively. Methods: We retrospectively reviewed 36 HCC patients who underwent liver resections during January 2017 to March 2018 in Chang Gung Memorial Hospital. Patients were grouped based on the status of CK19 expression and their baseline characteristics, perioperative and oncologic outcomes were compared. Novel biomarkers including NLR, alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA) and uric acid were analyzed and correlated with CK19 expression. Results: NLR is highly associated with CK19 expression. NLR alone gave an AUROC of 0.728 (<i>p</i>-value = 0.043), higher than AFP, CEA or tumor size alone. NLR when combined with AFP, CEA and uric acid, gave an AUROC as high as 0.933 (<i>p</i>-value = 0.004). Conclusion: The current study demonstrated the predictive capability of NLR in combination with AFP, CEA and uric acid for CK19 expression in HCC patients preoperatively. Further prospective, large-scale studies are warranted to validate our findings.Chao-Wei LeeSey-En LinMing-Chin YuHao-Wei KouCheng-Han LeeTony KuoKuan-Chieh LeeHsin-I TsaiMDPI AGarticleneutrophil to lymphocyte ratioNLRhepatocellular carcinomahepatomacytokeratin 19 (CK19)MedicineRENJournal of Personalized Medicine, Vol 11, Iss 1078, p 1078 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
neutrophil to lymphocyte ratio NLR hepatocellular carcinoma hepatoma cytokeratin 19 (CK19) Medicine R |
spellingShingle |
neutrophil to lymphocyte ratio NLR hepatocellular carcinoma hepatoma cytokeratin 19 (CK19) Medicine R Chao-Wei Lee Sey-En Lin Ming-Chin Yu Hao-Wei Kou Cheng-Han Lee Tony Kuo Kuan-Chieh Lee Hsin-I Tsai Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma? |
description |
Background: Cytokeratin 19-positive (CK19(+)) hepatocellular carcinomas (HCC) are generally associated with poor prognosis after hepatectomy. It is typically detected from postoperative immunochemistry. We have analyzed several clinically available biomarkers, in particular, neutrophil to lymphocyte ratio (NLR) and aim to develop a panel of biomarkers in identifying CK19 expression in (HCC) preoperatively. Methods: We retrospectively reviewed 36 HCC patients who underwent liver resections during January 2017 to March 2018 in Chang Gung Memorial Hospital. Patients were grouped based on the status of CK19 expression and their baseline characteristics, perioperative and oncologic outcomes were compared. Novel biomarkers including NLR, alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA) and uric acid were analyzed and correlated with CK19 expression. Results: NLR is highly associated with CK19 expression. NLR alone gave an AUROC of 0.728 (<i>p</i>-value = 0.043), higher than AFP, CEA or tumor size alone. NLR when combined with AFP, CEA and uric acid, gave an AUROC as high as 0.933 (<i>p</i>-value = 0.004). Conclusion: The current study demonstrated the predictive capability of NLR in combination with AFP, CEA and uric acid for CK19 expression in HCC patients preoperatively. Further prospective, large-scale studies are warranted to validate our findings. |
format |
article |
author |
Chao-Wei Lee Sey-En Lin Ming-Chin Yu Hao-Wei Kou Cheng-Han Lee Tony Kuo Kuan-Chieh Lee Hsin-I Tsai |
author_facet |
Chao-Wei Lee Sey-En Lin Ming-Chin Yu Hao-Wei Kou Cheng-Han Lee Tony Kuo Kuan-Chieh Lee Hsin-I Tsai |
author_sort |
Chao-Wei Lee |
title |
Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma? |
title_short |
Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma? |
title_full |
Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma? |
title_fullStr |
Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma? |
title_full_unstemmed |
Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma? |
title_sort |
does neutrophil to lymphocyte ratio have a role in identifying cytokeratin 19-expressing hepatocellular carcinoma? |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/a95080fe17b74e3cad83ec35b9eacc90 |
work_keys_str_mv |
AT chaoweilee doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma AT seyenlin doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma AT mingchinyu doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma AT haoweikou doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma AT chenghanlee doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma AT tonykuo doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma AT kuanchiehlee doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma AT hsinitsai doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma |
_version_ |
1718411634958925824 |